Twist Bioscience's IPO

Twist Bioscience raised a round of funding on October 31, 2018. Investors include Public.

Twist Bioscience (TWST) is a biotechnology company offering synthetic DNA production for specialty chemical compounds and drug development. By synthesizing DNA on silicon instead of on traditional 96-…

Articles about Twist Bioscience's IPO: